Cns Pharmaceuticals Inc (CNSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 10-1986 | 10-1985 | 10-1984 | |
| Assets | |||
| Current Assets | |||
| Other current assets | 259 | 159 | 100 |
| TOTAL | $259 | $159 | $100 |
| Non-Current Assets | |||
| PPE Net | 4,283 | 3,114 | 2,560 |
| Other Non-Current Assets | 6,588 | 6,975 | 5,942 |
| TOTAL | $10,871 | $10,089 | $8,502 |
| Total Assets | $11,130 | $10,249 | $8,601 |
| Liabilities | |||
| Current Liabilities | |||
| Short Term Debt | 2,128 | 3,000 | 541 |
| Accounts payable and accrued liabilities | 3,102 | 3,670 | 5,198 |
| Accrued Expenses | 1,172 | 1,200 | 380 |
| Other current liabilities | 0 | 0 | 73 |
| TOTAL | $7,459 | $7,870 | $6,337 |
| Non-Current Liabilities | |||
| Other Non-Current Liabilities | 337 | 273 | 239 |
| TOTAL | $713 | $464 | $288 |
| Total Liabilities | $8,172 | $8,334 | $6,626 |
| Shareholders' Equity | |||
| Common Shares | 30 | 19 | 13 |
| Other shareholders' equity | -106 | 0 | 0 |
| TOTAL | $10,553 | $7,119 | $500 |
| Total Liabilities And Equity | $18,725 | $15,453 | $7,126 |